These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32621739)

  • 41. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
    Sadun A; Gordon L
    J Neuroophthalmol; 2020 Mar; 40(1):117-121. PubMed ID: 31834197
    [No Abstract]   [Full Text] [Related]  

  • 43. Unresolved questions about the treatment of COVID-19 with corticosteroids.
    Corral-Gudino L; Abadía-Otero J; Gómez-Barquero J
    Med Clin (Barc); 2021 Feb; 156(3):143-144. PubMed ID: 33308854
    [No Abstract]   [Full Text] [Related]  

  • 44. Bloodstream infections in critically ill patients with COVID-19.
    Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M
    Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myopathy associated with severe SARS-CoV-2 infection.
    Abenza Abildúa MJ; Ramírez Prieto MT; Moreno Zabaleta R; Algarra Lucas C; Pérez López C
    Neurologia (Engl Ed); 2020; 35(9):706-708. PubMed ID: 32893072
    [No Abstract]   [Full Text] [Related]  

  • 46. [Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
    Mareev VY; Orlova YA; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Plisyk AG; Seredenina EM; Potapenko AV; Malakhov PS; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Asratyan DA; Zhdanova EA; Mareev YV; Begrambekova YL; Shatochina EA; Kamalov АА
    Kardiologiia; 2020 Oct; 60(9):4-21. PubMed ID: 33131470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
    Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
    Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality.
    Sinha P; Linas BP
    Clin Infect Dis; 2021 Dec; 73(11):2116-2118. PubMed ID: 33956936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
    Sagnelli C; Gentile V; Tirri R; Macera M; Cappabianca S; Ciccia F; Coppola N;
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32474034
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
    Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM.
    Klopfenstein T; Gendrin V; Zayet S
    Clin Microbiol Infect; 2022 Nov; 28(11):1519. PubMed ID: 35738319
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment strategies of COVID-19: A rheumatology perspective.
    Drosos AA; Pelechas E; Voulgari PV
    Eur J Intern Med; 2022 Aug; 102():17-23. PubMed ID: 35610165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.
    Başaran S; Şimşek-Yavuz S; Meşe S; Çağatay A; Medetalibeyoğlu A; Öncül O; Özsüt H; Ağaçfidan A; Gül A; Eraksoy H
    Int J Infect Dis; 2021 Apr; 105():756-762. PubMed ID: 33737128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.
    Potere N; Di Nisio M; Cibelli D; Scurti R; Frattari A; Porreca E; Abbate A; Parruti G
    Ann Rheum Dis; 2022 Nov; 81(11):e215. PubMed ID: 32737108
    [No Abstract]   [Full Text] [Related]  

  • 55. Response.
    Narain S; Stefanov DG; Marder G; Kaplan B; Hajizadeh N
    Chest; 2021 May; 159(5):2109-2110. PubMed ID: 33965136
    [No Abstract]   [Full Text] [Related]  

  • 56. Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.
    Hong JY; Ko JH; Yang J; Ha S; Nham E; Huh K; Cho SY; Kang CI; Chung DR; Baek JY; Sohn YM; Park HJ; Lee B; Huh HJ; Kang ES; Suh GY; Chung CR; Peck KR
    Yonsei Med J; 2022 May; 63(5):430-439. PubMed ID: 35512745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Review of the Evidence for Corticosteroids in COVID-19.
    Johns M; George S; Taburyanskaya M; Poon YK
    J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticosteroids for COVID-19: worth it or not?
    Akter F; Araf Y; Hosen MJ
    Mol Biol Rep; 2022 Jan; 49(1):567-576. PubMed ID: 34643927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early tocilizumab treatment could improve survival among COVID-19 patients.
    Campins L; Boixeda R; Perez-Cordon L; Aranega R; Lopera C; Force L
    Clin Exp Rheumatol; 2020; 38(3):578. PubMed ID: 32456769
    [No Abstract]   [Full Text] [Related]  

  • 60. Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
    Jiménez-Lozano I; Caro-Teller JM; Fernández-Hidalgo N; Miarons M; Frick MA; Batllori Badia E; Serrano B; Parramon-Teixidó CJ; Camba-Longueira F; Moral-Pumarega MT; San Juan-Garrido R; Cabañas Poy MJ; Suy A; Gorgas Torner MQ
    J Clin Pharm Ther; 2021 Aug; 46(4):1062-1070. PubMed ID: 33638257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.